Bank of Montreal
TVTX icon

Bank of Montreal’s Travere Therapeutics TVTX Stock Holding History

Bank of Montreal’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-75,919
Closed -$625K – 4243
2024
Q2 		$625K Buy
+75,919
New +$511K ﹤0.01% 2283
2022
Q1 		– Sell
-6,798
Closed -$206K – 4289
2021
Q4 		$206K Buy
+6,798
New +$191K ﹤0.01% 2949
2021
Q3 		– Sell
-125,437
Closed -$1.88M – 3954
2021
Q2 		$1.88M Buy
125,437
+2,767
+2% +$54.6K ﹤0.01% 2096
2021
Q1 		$3.1M Sell
122,670
-51,604
-30% -$1.43M ﹤0.01% 1574
2020
Q4 		$4.78M Sell
174,274
-20,549
-11% -$480K ﹤0.01% 1412
2020
Q3 		$4M Sell
194,823
-2,356
-1% -$45.8K ﹤0.01% 1340
2020
Q2 		$3.97M Buy
197,179
+3,490
+2% +$55.6K ﹤0.01% 1278
2020
Q1 		$2.91M Buy
193,689
+29,244
+18% +$440K ﹤0.01% 1246
2019
Q4 		$2.34M Buy
164,445
+17,344
+12% +$222K ﹤0.01% 1793
2019
Q3 		$1.71M Sell
147,101
-12,512
-8% -$207K ﹤0.01% 1790
2019
Q2 		$3.21M Sell
159,613
-14,226
-8% -$281K ﹤0.01% 1431
2019
Q1 		$3.93M Sell
173,839
-2,505
-1% -$55.4K ﹤0.01% 1304
2018
Q4 		$3.99M Sell
176,344
-3,754
-2% -$93.4K ﹤0.01% 1194
2018
Q3 		$5.17M Buy
180,098
+20,019
+13% +$572K ﹤0.01% 1165
2018
Q2 		$4.36M Sell
160,079
-16,123
-9% -$429K ﹤0.01% 1236
2018
Q1 		$3.94M Sell
176,202
-5,214
-3% -$124K ﹤0.01% 1264
2017
Q4 		$3.82M Buy
181,416
+61,634
+51% +$1.41M ﹤0.01% 1255
2017
Q3 		$2.98M Buy
119,782
+6,598
+6% +$145K ﹤0.01% 1411
2017
Q2 		$2.19M Sell
113,184
-11,682
-9% -$212K ﹤0.01% 1576
2017
Q1 		$2.31M Buy
124,866
+47,604
+62% +$931K ﹤0.01% 1454
2016
Q4 		$1.58M Buy
77,262
+31,928
+70% +$653K ﹤0.01% 1685
2016
Q3 		$1.01M Buy
45,334
+24,654
+119% +$469K ﹤0.01% 1820
2016
Q2 		$368K Buy
20,680
+20,326
+5,742% +$329K ﹤0.01% 2214
2016
Q1 		$5K Sell
354
-6,346
-95% -$96.3K ﹤0.01% 3797
2015
Q4 		$129K Buy
6,700
+6,336
+1,741% +$127K ﹤0.01% 2653
2015
Q3 		$7K Buy
+364
New +$10.8K ﹤0.01% 3578
2014
Q3 		– Sell
-6,555
Closed -$77K – 4401
2014
Q2 		$77K Buy
6,555
+622
+10% +$8.43K ﹤0.01% 2992
2014
Q1 		$126K Buy
+5,933
New +$91.2K ﹤0.01% 2698

Other funds holding TVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of Montreal's TVTX Position: Q3 2024 in Review

Bank of Montreal sold out of Travere Therapeutics (TVTX) in Q3 2024, closing a stake of 75,919 shares — an estimated $625K sold.

Bank of Montreal first reported a position in TVTX in Q1 2014 and held it in 28 quarters. The position peaked at $5.17M in Q3 2018. 178 funds tracked by Wall St. Rank hold TVTX as of Q3 2024.

  • Bank of Montreal reported no remaining Travere Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 75,919 Travere Therapeutics shares in Q3 2024, an estimated $625K.
  • Bank of Montreal first reported a position in Travere Therapeutics in Q1 2014 and held it in 28 quarters.
  • Bank of Montreal's Travere Therapeutics position peaked at $5.17M in Q3 2018.
  • 178 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.